Current Status of Immunomodulatory and Cellular Therapies in Preclinical and Clinical Islet Transplantation
Clinical islet transplantation is a 𝛽-cell replacement strategy that represents a possible definitive intervention for patients with type 1 diabetes, offering substantial benefits in terms of lowering daily insulin requirements and reducing incidences of debilitating hypoglycemic episodes and unawar...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2011-01-01
|
Series: | Journal of Transplantation |
Online Access: | http://dx.doi.org/10.1155/2011/637692 |